Series C Investors & VC Firms in United Kingdom

240 firms in this list, with a median first check of $1M. 15 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SC SC Ventures GJAMSEL16 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
IN In-Q-Tel ABDGDJDM11 people	88🔒	Tysons	US	Seed–Growth	$100K – $2.5M	+ Add to CRM
SC Scottish Equity Partners ADACCPJR18 people · Leads rounds	88🔒	Glasgow	GB	Series A–Late Stage	$2.5M – $31.8M	+ Add to CRM
RI Ribbit Capital MMBPCMJA12 people · Leads rounds	88🔒	Palo Alto	US	Seed–Growth	$100K – $15M	+ Add to CRM
AT At One Ventures HLLMTCLZ4 people	88🔒	Menlo Park	US	Pre-Seed–Growth	—	+ Add to CRM
VE Ventech ACASCCCH10 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
CH Channel 4 Ventures HRJGVS3 people · Follows rounds	88🔒	London	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
SP Spectrum Equity AMBRLPMF9 people · Leads rounds	88🔒	Boston	US	Series A–Late Stage	$25M – $250M	+ Add to CRM
HO HongShan NSCCEPEI11 people · Leads rounds	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	$100K – $50M	+ Add to CRM
SA Salesforce Ventures CEJSPDEZ5 people	88🔒	London	GB	Pre-Seed–Growth	—	+ Add to CRM
HA Hakluyt Capital JPNBATMH8 people	88🔒	London	GB	Series B–Late Stage	—	+ Add to CRM
GE Georgian APEWEKFS11 people	88🔒	Toronto, Ontario	CA	Series B–Late Stage	$25M – $100M	+ Add to CRM
PA Parkwalk Advisors AKAWKZMG11 people	88🔒	London	GB	Seed–Growth	—	+ Add to CRM
BL Blume Ventures KRSNAAAF11 people	88🔒	Mumbai	IN	Seed–Late Stage	$50K – $300K	+ Add to CRM
OX Oxford Follows rounds	88🔒	Oxford	GB	Pre-Seed–Late Stage	—	+ Add to CRM
VE Venture Founders	88🔒	London	GB	Series A–Growth	—	+ Add to CRM
TR True Global Ventures	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
AT Atlantic Vantage Point ASBFDMFR11 people	88🔒	Paris	FR	Seed–Late Stage	$1M – $20M	+ Add to CRM
DA Dawn Capital LLP DCEPHOHM11 people	88🔒	London	GB	Series A–Growth	$317.5K – $6.3M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Seed–Late Stage	$10.8M – $64.8M	+ Add to CRM
ET ETF Partners PSFBLRRD11 people	88🔒	London	GB	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
FL Flashpoint Venture Capital AKAFDMIB11 people	88🔒	London	GB	Seed–Late Stage	$1M – $15M	+ Add to CRM
FO Foresight Group PECADWDH11 people	88🔒	Sydney Nsw	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM

SC Ventures

SingaporeSeed–Late Stage

GJAMSEL16 people

In-Q-Tel

TysonsSeed–Growth$100K – $2.5M

ABDGDJDM11 people

Scottish Equity Partners

GlasgowSeries A–Late Stage$2.5M – $31.8M

ADACCPJR18 people

Ribbit Capital

Palo AltoSeed–Growth$100K – $15M

MMBPCMJA12 people

At One Ventures

Menlo ParkPre-Seed–Growth

HLLMTCLZ4 people

Ventech

ParisSeed–Growth$540K – $5.4M

ACASCCCH10 people

Channel 4 Ventures

LondonSeed–Late Stage$1.3M – $6.3M

HRJGVS3 people

Spectrum Equity

BostonSeries A–Late Stage$25M – $250M

AMBRLPMF9 people

HongShan

Hong KongPre-Seed–Late Stage$100K – $50M

NSCCEPEI11 people

Salesforce Ventures

LondonPre-Seed–Growth

CEJSPDEZ5 people

Hakluyt Capital

LondonSeries B–Late Stage

JPNBATMH8 people

Georgian

Toronto, OntarioSeries B–Late Stage$25M – $100M

APEWEKFS11 people

Parkwalk Advisors

LondonSeed–Growth

AKAWKZMG11 people

Blume Ventures

MumbaiSeed–Late Stage$50K – $300K

KRSNAAAF11 people

Oxford

OxfordPre-Seed–Late Stage

Venture Founders

LondonSeries A–Growth

True Global Ventures

San FranciscoSeed–Late Stage

Atlantic Vantage Point

ParisSeed–Late Stage$1M – $20M

ASBFDMFR11 people

Dawn Capital LLP

LondonSeries A–Growth$317.5K – $6.3M

DCEPHOHM11 people

EQT Life Sciences

AmsterdamSeed–Late Stage$10.8M – $64.8M

APFVFAJR11 people

ETF Partners

LondonSeries A–Growth$5.4M – $16.2M

PSFBLRRD11 people

Flashpoint Venture Capital

LondonSeed–Late Stage$1M – $15M

AKAFDMIB11 people

Foresight Group

Sydney NswSeed–Late Stage$1.3M – $6.3M

PECADWDH11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Data sourced from public filings and firms' own websites — see our methodology.